Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
13 hedge funds and large institutions have $302K invested in Biocept, Inc. in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
8% more funds holding
Funds holding: 12 → 13 (+1)
26% less capital invested
Capital invested by funds: $406K → $302K (-$104K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
+$28.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15.8K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$3.17K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$864 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$30K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$9.79K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| 4 |
Barclays
London,
United Kingdom
|
-$288 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $127K | – | – | – |
|
2
Geode Capital Management
Boston,
Massachusetts
| $57K | – | – | – |
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $28K | – | – | – |
|
|
ARTA
4
A.R.T. Advisors
New York
| $24K | +$28.8K | +100 | New |
|
5
BlackRock
New York
| $22K | – | – | – |
|
6
Northern Trust
Chicago,
Illinois
| $18K | – | – | – |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $13K | +$15.8K | +55 | New |
|
|
8
Ameriprise
Minneapolis,
Minnesota
| $8K | -$9.79K | -34 | -51% |
|
|
9
Victory Capital Management
San Antonio,
Texas
| $3K | +$3.17K | +11 | New |
|
10
US Bancorp
Minneapolis,
Minnesota
| $1K | – | – | – |
|
|
11
Bank of America
Charlotte,
North Carolina
| $1K | +$864 | +3 | New |
|
|
FDCDDQ
12
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $298 | – | – | – |
|
|
VF
13
Virtu Financial
New York
| – | -$30K | -89 | Closed |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$9K | -27 | Closed |
|
|
15
Barclays
London,
United Kingdom
| – | -$288 | -1 | Closed |
|
BIOC Hedge Fund Activity: Q3 2019 in Review
13 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q3 2019, worth a combined $302K — down 26% from $406K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BIOC positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was A.R.T. Advisors, opening a new position worth an estimated $28.8K. The largest seller was Virtu Financial, exiting entirely with an estimated $30K sold.
- 13 institutional investors held Biocept, Inc. (BIOC) as of Q3 2019, up from 12 in Q2 2019.
- Funds reported $302K of Biocept, Inc. stock for Q3 2019, down 26% quarter-over-quarter.
- 4 funds opened new Biocept, Inc. positions in Q3 2019 and 3 closed out, a net change of +1 holder.
- The largest Biocept, Inc. buyer in Q3 2019 was A.R.T. Advisors, an estimated $28.8K added.
- The largest Biocept, Inc. seller in Q3 2019 was Virtu Financial, an estimated $30K sold.
Based on aggregated 13F filings for Q3 2019.